Sartorius Stedim Biotech S.A. (EPA:DIM)
France · Delayed Price · Currency is EUR 163.30
-2.20 (-1.33%)
Jun 19, 2026, 5:35 PM CET
Sartorius Stedim Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Buy Maintains €233.00 → €230.00 | Buy | Maintains | €233.00 → €230.00 | +40.85% | Jun 3, 2026 |
| RBC Capital | RBC Capital | Buy Maintains €210.00 | Buy | Maintains | €210.00 | +28.60% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains €220.00 | Buy | Maintains | €220.00 | +34.72% | Apr 23, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +59.22% | Apr 23, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains €214.00 | Buy | Maintains | €214.00 | +31.05% | Apr 23, 2026 |
| UBS | UBS | Hold Maintains €220.00 | Hold | Maintains | €220.00 | +34.72% | Apr 17, 2026 |
| Kepler Capital | Kepler Capital | Buy Upgrades n/a | Buy | Upgrades | n/a | n/a | Mar 18, 2026 |
| Jefferies | Jefferies | Buy Maintains €256.00 → €262.00 | Buy | Maintains | €256.00 → €262.00 | +60.44% | Mar 17, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.